mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-10 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
1e-09 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-09 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
3e-09 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-09 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
3e-09 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-09 |